← Back
$RYTM All transactions

RHYTHM PHARMACEUTICALS, INC.

M 10b5-1 Plan

$ Value

$0

Shares

3,125

Price

$0

Filed

Jul 29

Insider

Name

Cramer Pamela J.

Title

Chief Human Resources Officer

CIK

0001873517

Roles

Officer

Transaction Details

Transaction Date

2025-07-26

Code

M

Table

Derivative

Ownership

Direct

Equity Swap

No

Shares After

Footnotes

Each restricted stock unit represents a contingent right to receive one share of Issuer common stock. | The sale reported in the Form 4 was effected pursuant to a Rule 10b5-1 instruction adopted prior to February 27, 2023 solely with the intent to cover withholding taxes in connection with the vesting of certain previously reported restricted stock units. | The restricted stock units vest as to 25% of the total shares on each of July 26, 2022, July 26, 2023, July 26, 2024 and July 26, 2025. The restricted stock units have no expiration date.

Filing Info

Accession No.

0001104659-25-071849

Form Type

4

Issuer CIK

0001649904

Cramer Pamela J.'s History

Date Ticker Type Value
2026-02-01 RYTM M
2026-02-01 RYTM F $516K
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2026-02-01 RYTM M $0
2025-12-11 RYTM M $92K
2025-12-11 RYTM $372K
2025-12-11 RYTM M $0
2025-11-20 RYTM M $92K

Other Insiders at RYTM (90d)

Insider Bought Sold Last
German Christopher Paul
Corporate Controller & CAO
2026-02-01
Popovits Kimberly J 2026-04-01
Meeker David P
President and CEO
2026-02-01
Smith Hunter C
Chief Financial Officer
$703K 2026-02-05
Mazabraud Yann
EVP, Head of International
2026-04-01
Lee Jennifer Kayden
EVP, Head of North America
2026-02-01
Cramer Pamela J.
Chief Human Resources Officer
2026-02-01
Shulman Joseph
Chief Technical Officer
2026-02-01
Garfield Alastair
Chief Scientific Officer
2026-02-01